Stockscreener 앱 받기
2.66
1.48%
-0.04
시간 외 거래:
2.66
전일 마감가:
$2.70
열려 있는:
$2.71
하루 거래량:
54,831
Relative Volume:
0.71
시가총액:
$136.12M
수익:
$63.69M
순이익/손실:
$-44.82M
주가수익비율:
-1.33
EPS:
-2
순현금흐름:
$-30.56M
1주 성능:
+9.47%
1개월 성능:
+22.02%
6개월 성능:
+43.78%
1년 성능:
+3.10%
1일 변동 폭
$2.60
$2.75
1주일 범위
$2.40
$2.93
52주 변동 폭
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
MDXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
2.66 | 136.12M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 개시 | Craig Hallum | Buy |
| 2024-10-31 | 개시 | Lake Street | Buy |
| 2023-05-31 | 개시 | TD Cowen | Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
Mdxhealth Sa 주식(MDXH)의 최신 뉴스
Using RSI to spot recovery in MDxHealth SAEarnings Report Summary with Market Impact - Newser
Why MDxHealth SA stock attracts strong analyst attentionFree Consistent Income Focused Trade List - Newser
Automated trading signals detected on MDxHealth SAMarket Forecast Summary Over Multi-Year Period - Newser
News impact scoring models applied to MDxHealth SAFree Step-by-Step Trade Signal Implementation - Newser
Earnings visualization tools for MDxHealth SAConsistent Gain Plan with AI Support - Newser
Is MDxHealth SA forming a bottoming baseStock Performance Summary Over One Year - Newser
Financial Analysis: MDxHealth (NASDAQ:MDXH) and Standard BioTools (NASDAQ:LAB) - Defense World
MDxHealth SA stock prediction for this weekDaily Market Entry Strategy with Tools - Newser
Order flow analysis tools used on MDxHealth SAReal Trader Watchlist with Entry Targets - Newser
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Will MDxHealth SA stock recover after recent dropFree Community Verified Stock Suggestions - Newser
MDxHealth ADR earnings missed by $0.03, revenue topped estimates - Investing.com South Africa
MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics - TipRanks
Bio-Techne announces Exosome Diagnostics divestiture - MSN
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com Australia
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
MDxHealth Hits Profitability Milestone and Expands Diagnostic Portfolio with Strategic $15M ExoDx Acquisition - Stock Titan
MACD Cross Could Confirm Trend in MDxHealth SATarget Return Focused Trade Insights Shared - metal.it
Is MDxHealth SA a growth stock or a value stockOutstanding capital growth - Jammu Links News
When is MDxHealth SA stock expected to show significant growthUnlock expert trading strategies for growth - Jammu Links News
What are the latest earnings results for MDxHealth SACapitalize on momentum-driven investment opportunities - Jammu Links News
Is MDxHealth SA stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Why is MDxHealth SA stock attracting strong analyst attentionMaximize returns with expert trading insights - Jammu Links News
How does MDxHealth SA compare to its industry peersExceptional stock performance - Jammu Links News
How many analysts rate MDxHealth SA as a “Buy”Unlock powerful market trend analysis - Jammu Links News
What makes MDxHealth SA stock price move sharplyUnlock exclusive trading strategies - Jammu Links News
What catalysts could drive MDxHealth SA stock higher in 2025Free Stock Market Trend Analysis - Jammu Links News
What drives MDxHealth SA stock priceSuperior profit margins - Jammu Links News
Is it the right time to buy MDxHealth SA stockUnlock exclusive trading strategies - Jammu Links News
What are the technical indicators suggesting about MDxHealth SACapitalize on market trends with confidence - Jammu Links News
What are analysts’ price targets for MDxHealth SA in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
What institutional investors are buying MDxHealth SA stockUnprecedented growth rates - jammulinksnews.com
Competitive Positioning of MDxHealth SA: Is It Leading or LaggingBuy and Exit Strategy Based on Momentum - Newser
Statistical indicators supporting MDxHealth SA’s strengthSwing Entry Insight With Forecast Accuracy - Newser
Mdxhealth Sa (MDXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):